Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Hilton Lac-Leamy

14 nov 2024 7:30 a.m. - 15 nov 2024 4:10 p.m.

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Session 4, Track B: Decentralized Clinical Trials – Canada’s First Case Study and Next Steps

Session Chair(s)

Stephanie  Anderson, MS

Stephanie Anderson, MS

Associate Director, Regulatory Affairs

Intrinsik Corp., Canada

The global COVID-19 pandemic has catalyzed substantial advancements in the establishment and execution of decentralized clinical trials (DCTs) in Canada. This session will offer a glimpse into the experiences and findings from Canada’s first fully decentralized trial. Furthermore, we will delve into a proposed framework for hybrid DCTs, sharing experiences to date, lessons learned, and a vision for the future. Keeping our commitment to patient-centricity, we will also discuss the perceived advantages and challenges of DCTs from the perspectives of patients, caregivers, and their families.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe different DCT models and understand methods to implement them
  • Discuss the advantages and challenges with implementing DCTs
  • Recognize the patient perspective when implementing DCTs

Speaker(s)

Aneta  Woroniecka-Osio, MD

Operational Implementation of Decentralized Clinical Trials advances participant-centric research

Aneta Woroniecka-Osio, MD

Bayer HealthCare Pharmaceuticals, Canada

Decentralized Clinical Trial Strategy Development Lead

Roel  Schlijper-Bos

Decentralized Clinical Trials – BC Cancer Perspective and Experiences

Roel Schlijper-Bos

BC Cancer, Canada

Clinical Research Unit Manager

Maureen  Smith, MEd

Patient and Public Perceptions in Canada About Decentralized and Hybrid Clinical Trials: “It’s About Time We Bring Trials to People”

Maureen Smith, MEd

Clinical Trials Ontario College of Lived Experience, Canada

Member

Emily I McIntosh, PhD

Patient and Public Perceptions in Canada About Decentralized and Hybrid Clinical Trials: “It’s About Time We Bring Trials to People”

Emily I McIntosh, PhD

Clinical Trials Ontario, Canada

College of Lived Experience Member

Dawn P. Richards, PhD

Participant Perception of Decentralized Clinical Trials and Next Steps

Dawn P. Richards, PhD

Clinical Trials Ontario, Canada

Director, Patient and Public Engagement

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.